论文信息 - FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma - 字舞流文

FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma

Amy McKee | R. Pazdur | B. George | Y. Kasamon | G. Blumenthal | Shiowjen Lee | R. A. de Claro | W. Bryan | N. Bouchkouj | Xue Lin | R. A. Claro | R. A. D. Claro